Acuity (NYSE: AYI) director granted 546 restricted shares as fees

Rhea-AI Filing Summary

Acuity Inc. director James H. Hance Jr. reported receiving a restricted stock award of 546 shares of common stock on January 21, 2026. The shares were valued at $320.59 per share and were taken in lieu of a portion of his annual director fees, reflecting compensation paid in stock instead of cash.

After this grant, Hance directly beneficially owns 18,618 shares of Acuity Inc. common stock. The restricted stock will vest in full on the first anniversary of the grant date, or earlier if the next annual meeting of stockholders occurs before that date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HANCE JAMES H JR

(Last) (First) (Middle)

C/O ACUITY INC.

1170 PEACHTREE STREET, NE, STE. 1200

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACUITY INC. (DE) [ AYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/21/2026		A		546(1)	A	$320.59	18,618	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Award (RSA) issued pursuant to the Issuer's Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan. The RSA resulted from the Reporting Person's election to receive a portion of annual director fees payable on January 21, 2026 in the form of an RSA. The RSA will vest in full on the first anniversary of the grant date, or, if earlier, the date of the next subsequent annual meeting of the Issuer's stockholders following the grant date.

Remarks:

	/s/ Chanda Kirchner, Attorney-in-Fact for James H. Hance, Jr.	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Acuity Inc. (AYI) disclose in this Form 4?

The filing shows that director James H. Hance Jr. received a restricted stock award of 546 shares of Acuity Inc. common stock on January 21, 2026 as part of his director compensation.

How many Acuity Inc. (AYI) shares did James H. Hance Jr. receive and at what price?

James H. Hance Jr. acquired 546 shares of Acuity Inc. common stock at a value of $320.59 per share, recorded as an acquisition in the Form 4.

Why was the restricted stock award granted to the Acuity (AYI) director?

The restricted stock award (RSA) resulted from Hance's election to receive a portion of his annual director fees payable on January 21, 2026 in the form of an RSA instead of cash.

What are the vesting terms of the restricted stock awarded to the Acuity (AYI) director?

The RSA will vest in full on the first anniversary of the grant date, or, if earlier, on the date of the next subsequent annual meeting of Acuity Inc.'s stockholders following the grant date.

How many Acuity Inc. (AYI) shares does James H. Hance Jr. own after this transaction?

Following the reported transaction, James H. Hance Jr. beneficially owns 18,618 shares of Acuity Inc. common stock, held with direct ownership.

Is this Acuity (AYI) Form 4 transaction a purchase on the open market?

No. The filing describes the transaction as a restricted stock award issued under Acuity Inc.'s Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan, tied to director fees, not an open-market trade.